Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Theilacker

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
The Pediatric Infectious Disease Journal|June 10, 2026
Safety and Immunogenicity of 20-valent Pneumococcal Conjugate Vaccine According to Number and Timing of Primary Series DosesMary Kline, Anne L Wyllie, Kathleen McElwee, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2024
Case-fatality rate of invasive pneumococcal disease caused by various serotypes-an analysis of nationwide surveillance data from Israel, 2009-2018Anat Wieder-Finesod, Dafna Yahav, Carmit Rubin, et al.
The Journal of Infectious Diseases|March 11, 2024
Effect of Pneumococcal Conjugate Vaccines on Viral Respiratory Infections: A Systematic Literature ReviewIngrid T Sepúlveda-Pachón, Eileen M Dunne, Germaine Hanquet, et al.
Journal of Medical Economics|July 21, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in GermanyJohnna Perdrizet, Dominik Schröder, Felicitas Kühne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2022
Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal VaccinationLindsay R Grant, Mary P E Slack, Christian Theilacker, et al.
The Journal of Biological Chemistry|April 28, 2009
Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cellsIrina G Sava, Fuming Zhang, Ioana Toma, et al.
Vaccine|August 6, 2023
Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policiesLindsay R Grant, Mary P E Slack, Christian Theilacker, et al.
ERJ Open Research|June 1, 2023
<i>Streptococcus pneumoniae</i> re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021Juliane Ankert, Stefan Hagel, Claudia Schwarz, et al.
The Journal of Infection|June 9, 2018
Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014Winfried V Kern, Susanne Weber, Markus Dettenkofer, et al.
Vaccine|March 29, 2024
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistanceLindsay R Grant, Germaine Hanquet, Ingrid T Sepúlveda-Pachón, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
The Pediatric Infectious Disease Journal|June 10, 2026
Safety and Immunogenicity of 20-valent Pneumococcal Conjugate Vaccine According to Number and Timing of Primary Series DosesMary Kline, Anne L Wyllie, Kathleen McElwee, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 17, 2024
Case-fatality rate of invasive pneumococcal disease caused by various serotypes-an analysis of nationwide surveillance data from Israel, 2009-2018Anat Wieder-Finesod, Dafna Yahav, Carmit Rubin, et al.
The Journal of Infectious Diseases|March 11, 2024
Effect of Pneumococcal Conjugate Vaccines on Viral Respiratory Infections: A Systematic Literature ReviewIngrid T Sepúlveda-Pachón, Eileen M Dunne, Germaine Hanquet, et al.
Journal of Medical Economics|July 21, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in GermanyJohnna Perdrizet, Dominik Schröder, Felicitas Kühne, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 5, 2022
Distribution of Serotypes Causing Invasive Pneumococcal Disease in Children From High-Income Countries and the Impact of Pediatric Pneumococcal VaccinationLindsay R Grant, Mary P E Slack, Christian Theilacker, et al.
The Journal of Biological Chemistry|April 28, 2009
Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cellsIrina G Sava, Fuming Zhang, Ioana Toma, et al.
Vaccine|August 6, 2023
Distribution of serotypes causing invasive pneumococcal disease in older adults from high-income countries and impact of pediatric and adult vaccination policiesLindsay R Grant, Mary P E Slack, Christian Theilacker, et al.
ERJ Open Research|June 1, 2023
<i>Streptococcus pneumoniae</i> re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021Juliane Ankert, Stefan Hagel, Claudia Schwarz, et al.
The Journal of Infection|June 9, 2018
Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014Winfried V Kern, Susanne Weber, Markus Dettenkofer, et al.
Vaccine|March 29, 2024
Effects of PCV10 and PCV13 on pneumococcal serotype 6C disease, carriage, and antimicrobial resistanceLindsay R Grant, Germaine Hanquet, Ingrid T Sepúlveda-Pachón, et al.
Pageof 7